Live Breaking News & Updates on Moderna booster shot

Stay informed with the latest breaking news from Moderna booster shot on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Moderna booster shot and stay connected to the pulse of your community

Treasurer of the State of North Carolina Buys 2,451 Shares of Moderna, Inc. (NASDAQ:MRNA)

Treasurer of the State of North Carolina boosted its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 1.1% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 215,752 shares of the company’s stock after acquiring an additional 2,451 shares during the period. Treasurer of the State of North Carolina’s holdings in […]

United-states , Canada , Stephen-hoge , Arpa-garay , Royal-bank , Shaughnessy-asset-management , Profund-advisors , Parkside-financial-bank , Nasdaq , Canaccord-genuity-group , Oak-associates-ltd , Moderna-inc

Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Treasurer of the State of North Carolina

Treasurer of the State of North Carolina lifted its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 1.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 215,752 shares of the company’s stock after acquiring an additional 2,451 shares during […]

United-states , Arpa-garay , Nasdaq , Invesco-ltd , Canaccord-genuity-group , Morgan-stanley , Moderna-inc , Securities-exchange-commission , Renaissance-technologies , Norges-bank , Goldman-sachs-group , Barclays-plc

Brokers Offer Predictions for Moderna, Inc.'s Q1 2024 Earnings (NASDAQ:MRNA)

Moderna, Inc. (NASDAQ:MRNA – Free Report) – Brookline Capital Management increased their Q1 2024 earnings per share estimates for Moderna in a research report issued to clients and investors on Thursday, February 22nd. Brookline Capital Management analyst L. Cann now anticipates that the company will post earnings of ($3.49) per share for the quarter, up […]

Canada , United-states , Ogorek-anthony-joseph , Stephen-hoge , Royal-bank , Jpmorgan-chase-co , Canaccord-genuity-group , Moderna-inc , Group-wealth-management , Nasdaq , Stonebridge-capital-advisors , Arlington-trust-co

Moderna (NASDAQ:MRNA) Shares Gap Down to $96.46

Moderna, Inc. (NASDAQ:MRNA – Get Free Report) shares gapped down before the market opened on Monday . The stock had previously closed at $96.46, but opened at $93.68. Moderna shares last traded at $93.58, with a volume of 679,558 shares changing hands. Analyst Upgrades and Downgrades Several analysts have commented on the stock. Deutsche Bank […]

United-states , Wellington , New-zealand-general- , New-zealand , Canada , Arpa-garay , Goldman-sachs-group , Vanguard-group-inc , Wellington-management-group , Royal-bank , Morgan-stanley , Moderna-inc

FDA says current Covid vaccines may need to be overhauled this winter - and updated every year - to keep up with evolving strains

The Food and Drug Administration ( FDA ) revealed Monday it was holding a meeting on which variant should be included in next winter's dose.

United-states , American , Pfizer , Centers-for-disease , Drug-administration , Products-advisory-committee , Related-biological-products-advisory-committee , Disease-control , Dailymail , Health , Moderna

CDC Meeting on RSV Vaccines Could Be Pivotal for GSK, Moderna

The agency’s vaccine advisory committee could offer clues about an eventual call on how often the vaccines are needed.

Michael-yee , Josh-nathan-kazis , Advisory-committee-on-immunization-practices , Drug-administration , Centers-for-disease , Pfizer , Getty-images , Disease-control , Advisory-committee , Immunization-practices , Article-normal , Biotechnology-services

Moderna Beat Quarterly Estimates Last Week. Here's Why One Analyst Says Sell.

HBSC downgraded the vaccine maker to Reduce from Hold in a Monday report.

Yifeng-liu , Emily-dattilo , Global-research , Prevention-advisory-committee-on-immunization-practices , Pfizer , Centers-for-disease , Getty-images , Wall-street , Disease-control , Advisory-committee , Immunization-practices , Article-normal

The fall COVID-19 shot's effectiveness, and other respiratory virus news this week

Influenza indicators are holding steady at levels that are at or below expected levels for this time of year

Canada , Prince-edward-island , Northwest-territories , United-kingdom , Quebec , British , Canadians , Canadian , Public-health-agency-of-canada , Canadian-institute-for-health-information , Health-canada

Moderna (NASDAQ:MRNA) Announces Quarterly Earnings Results

Moderna (NASDAQ:MRNA – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.55 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.78) by $1.33, Briefing.com reports. Moderna had a negative return on equity of 2.14% and a negative net margin of 38.00%. The company had revenue of $2.80 […]

United-states , Canada , Stephen-hoge , Moderna-inc , Royal-bank , Sunbelt-securities-inc , Moderna-company-profile , Stokes-family-office , Kraft-davis-associates , Canaccord-genuity-group , Loring-wolcott-coolidge-fiduciary-advisors , Deutsche-bank-aktiengesellschaft

Moderna (NASDAQ:MRNA) Receives Outperform Rating from Royal Bank of Canada

Royal Bank of Canada restated their outperform rating on shares of Moderna (NASDAQ:MRNA – Free Report) in a research note published on Friday, Benzinga reports. The brokerage currently has a $125.00 price target on the stock. Several other brokerages have also recently issued reports on MRNA. The Goldman Sachs Group dropped their price objective on […]

United-states , Canada , Stephen-hoge , Ogorek-anthony-joseph , Arpa-garay , Nasdaq , Eversource-wealth-advisors , Group-wealth-management , Moderna-inc , Royal-bank , Canaccord-genuity-group , Arlington-trust-co